Showing 1 - 20 results of 252 for search '"Регуляторные исследования и экспертиза лекарственных средств"', query time: 0.07s Refine Results
  1. 1

    ASPECTS OF MEDICINES QUALITY EVALUATION BY ELECTRICAL SENSING ZONE METHOD by E. S. Novik, A. V. Dorenskaya, N. A. Borisova, O. V. Gunar

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  2. 2

    Current Requirements for and Approaches to Dosing in Animal Studies by A. V. Rybakova, M. N. Makarova, A. E. Kukharenko, A. S. Vichare, F. R. Rueffer

    Published 2018-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  3. 3

    Control of the Purity of 93% Oxygen Obtained from the Air by Pressure Swing Adsorption by R. A. Enikeeva, Yu. V. Miroshnichenko, V. L. Bagirova, O. A. Popova

    Published 2022-10-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  4. 4

    Determination of the Critical Phases of the Experimental Research Using Laboratory Animals: Risk Analysis by S. V. Khodko, M. N. Makarova, V. G. Makarov, S. S. Salynov, N. V. Rodionova

    Published 2021-10-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  5. 5

    Alternative method for determining impurities in antimicrobial medicines by S. I. Kuleshova, T. I. Pshenichnykh, E. P. Simonova

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  6. 6

    Marketing Authorisation Based on Incomplete Clinical Data: International Experience and Prospects by D. V. Goryachev, N. E. Uvarova, G. V. Shukshina

    Published 2020-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  7. 7

    Problems of Establishing Limits for Arsenic Content in Brown Algae and Brown Algae-Containing Medicinal Products by V. M. Shchukin, A. A. Erina, E. A. Lisman, O. A. Vaganova

    Published 2019-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  8. 8

    Recommendations for the programme of clinical trials of medicinal products for the treatment of influenza by A. I. Gubenko, G. V. Shukshina, A. I. Muravieva, N. E. Uvarova

    Published 2023-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  9. 9

    Russian regulatory system for clinical trials is consistent with international approaches by Yu. N. Linkova

    Published 2023-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  10. 10

    Strategic Indicators in the Development of Original Medicinal Products in 2024: Analysis of Pipelines of International Pharmaceutical Leaders by L. S. Litvin, E. A. Kulikova

    Published 2023-08-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  11. 11

    Interchangeability of glibenclamide-containing drugs by G. I. Gorodetskaya, E. V. Shikh, M. V. Zhuravleva, S. Yu. Serebrova, E. A. Sokova, O. V. Muslimova, T. V. Aleksandrova, I. A. Mazerkina, S. G. Rudnev

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  12. 12

    Retraction of the article: Mironov A.N., Sakaeva I.V., Dudchenko V.V., Korneeva L.V., Yavorsky A.N. International experience in drug names assessment: european medicines agency by article Editorial

    Published 2022-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  13. 13

    Recommendations on Describing the Requirements for Microbiological Quality and Sterility of Medicinal Products by O. V. Gunar

    Published 2022-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  14. 14

    Current Approaches to the Abnormal Toxicity Test by N. P. Neugodova, E. O. Stepanyuk, G. A. Sapozhnikova, E. I. Sakanyan, M. S. Ryabtseva

    Published 2020-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  15. 15

    PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS by N. E. Uvarova, N. N. Eremenko, G. V. Ramenskaya, D. V. Goryachev

    Published 2018-12-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  16. 16

    SPECIFIC ASPECTS OF BENEFIT-RISK EVALUATION OF HERBAL MEDICINAL PRODUCTS: ANALYSIS OF REGISTRATION DOSSIERS by N. G. Olenina, N. S. Mikheeva, N. M. Krutikova

    Published 2018-06-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  17. 17

    Plan of action for carbapenem antibiotics sterility testing by S. I. Kuleshova, S. A. Protsak, S. A. Lisunova, G. Yu. Romanyuk, E. N. Semenova

    Published 2018-02-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  18. 18

    Endocrine Disorders Associated with Medicinal Products: Approaches to Preclinical Safety Assessment by K. L. Kryshen, N. M. Faustova, M. N. Makarova, V. G. Makarov

    Published 2023-03-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  19. 19

    Stability of Ready-to-Use and Laboratory-Prepared Culture Media by S. I. Kuleshova, S. A. Protsak, S. A. Lisunova, G. Yu. Romanyuk

    Published 2021-07-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article
  20. 20

    Vladimir Grigorievich Kukes (on the 85th Anniversary) by article Editorial

    Published 2019-09-01
    “…Регуляторные исследования и экспертиза лекарственных средств…”
    Get full text
    Article